Literature DB >> 28523565

Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins.

Saurabh Dhanda1, Rajat Sandhir2.   

Abstract

The present study was designed to investigate the mechanisms involved in blood-brain barrier (BBB) permeability in bile duct ligation (BDL) model of chronic hepatic encephalopathy (HE). Four weeks after BDL surgery, a significant increase was observed in serum bilirubin levels. Masson trichrome staining revealed severe hepatic fibrosis in the BDL rats. 99mTc-mebrofenin retention was increased in the liver of BDL rats suggesting impaired hepatobiliary transport. An increase in permeability to sodium fluorescein, Evans blue, and fluorescein isothiocyanate (FITC)-dextran along with increase in water and electrolyte content was observed in brain regions of BDL rats suggesting disrupted BBB. Increased brain water content can be attributed to increase in aquaporin-4 mRNA and protein expression in BDL rats. Matrix metalloproteinase-9 (MMP-9) mRNA and protein expression was increased in brain regions of BDL rats. Additionally, mRNA and protein expression of tissue inhibitor of matrix metalloproteinases (TIMPs) was also increased in different regions of brain. A significant decrease in mRNA expression and protein levels of tight junction proteins, viz., occludin, claudin-5, and zona occluden-1 (ZO-1) was observed in different brain regions of BDL rats. VCAM-1 mRNA and protein expression was also found to be significantly upregulated in different brain regions of BDL animals. The findings from the study suggest that increased BBB permeability in HE involves activation of MMP-9 and loss of tight junction proteins.

Entities:  

Keywords:  Aquaporins; Bile duct ligation; Blood-brain barrier; Hepatic encephalopathy; Matrix metalloproteinases; Tight junction proteins

Mesh:

Substances:

Year:  2017        PMID: 28523565     DOI: 10.1007/s12035-017-0521-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  83 in total

Review 1.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

2.  Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells.

Authors:  Stephen J Crocker; Richard Milner; Ngan Pham-Mitchell; Iain L Campbell
Journal:  J Neurochem       Date:  2006-08       Impact factor: 5.372

3.  Aquaporin-4 deletion in mice reduces encephalopathy and brain edema in experimental acute liver failure.

Authors:  Kakulavarapu V Rama Rao; A S Verkman; Kevin M Curtis; Michael D Norenberg
Journal:  Neurobiol Dis       Date:  2013-12-07       Impact factor: 5.996

4.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure.

Authors:  Naoki Shimojima; Christopher B Eckman; Michael McKinney; Daniel Sevlever; Satoshi Yamamoto; Wenlang Lin; Dennis W Dickson; Justin H Nguyen
Journal:  J Invest Surg       Date:  2008 May-Jun       Impact factor: 2.533

Review 6.  Brain edema in acute liver failure and chronic liver disease: similarities and differences.

Authors:  Cristina R Bosoi; Christopher F Rose
Journal:  Neurochem Int       Date:  2013-01-31       Impact factor: 3.921

7.  Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure.

Authors:  Kei Sawara; Paul Desjardins; Nicolas Chatauret; Akinobu Kato; Kazuyuki Suzuki; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-02-13       Impact factor: 3.921

8.  Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.

Authors:  D Häussinger; J Laubenberger; S vom Dahl; T Ernst; S Bayer; M Langer; W Gerok; J Hennig
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

9.  Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling.

Authors:  Arumugam R Jayakumar; Mingli Liu; Mitsuaki Moriyama; Ramugounder Ramakrishnan; Bliss Forbush; Pichili V B Reddy; Michael D Norenberg
Journal:  J Biol Chem       Date:  2008-10-10       Impact factor: 5.157

10.  Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia.

Authors:  W Young; Z H Rappaport; D J Chalif; E S Flamm
Journal:  Stroke       Date:  1987 Jul-Aug       Impact factor: 7.914

View more
  21 in total

Review 1.  Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.

Authors:  Rafael Ochoa-Sanchez; Christopher F Rose
Journal:  J Clin Exp Hepatol       Date:  2018-08-18

2.  Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.

Authors:  Saurabh Dhanda; Aditya Sunkaria; Avishek Halder; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2017-11-14       Impact factor: 3.584

3.  An isogenic hiPSC-derived BBB-on-a-chip.

Authors:  Pedram Motallebnejad; Andrew Thomas; Sarah L Swisher; Samira M Azarin
Journal:  Biomicrofluidics       Date:  2019-11-22       Impact factor: 2.800

4.  Mitochondrial Changes in Rat Brain Endothelial Cells Associated with Hepatic Encephalopathy: Relation to the Blood-Brain Barrier Dysfunction.

Authors:  Krzysztof Milewski; Karolina Orzeł-Gajowik; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2022-08-02       Impact factor: 4.414

5.  LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.

Authors:  Yong-Liang Du; Yan Liang; Yan Cao; Le Liu; Jian Li; Guang-Qing Shi
Journal:  Biochem Genet       Date:  2020-10-14       Impact factor: 1.890

6.  Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice.

Authors:  Stephanie Grant; Matthew McMillin; Gabriel Frampton; Anca D Petrescu; Elaina Williams; Victoria Jaeger; Jessica Kain; Sharon DeMorrow
Journal:  Gene Expr       Date:  2018-06-12

7.  Bilirubin: a novel predictor of hemorrhagic transformation and symptomatic intracranial hemorrhage after mechanical thrombectomy.

Authors:  Yating Jian; Lili Zhao; Heying Wang; Tao Li; Lei Zhang; Man Sun; Meijuan Dang; Ye Li; Yiheng Zhang; Jiao Liu; Hong Sun; Huqing Wang; Ru Zhang; Yi Jia; Hongxing Zhang; Guilian Zhang
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

8.  The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide.

Authors:  Somayeh Hajipour; Alireza Sarkaki; Mahin Dianat; Mohammad Rashno; Laaya Sadat Khorsandi; Yaghoob Farbood
Journal:  Metab Brain Dis       Date:  2021-02-23       Impact factor: 3.584

Review 9.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

10.  A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats.

Authors:  Sonia Tarazona; Héctor Carmona; Ana Conesa; Marta Llansola; Vicente Felipo
Journal:  Cell Biol Toxicol       Date:  2021-01-06       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.